Skip to main content
Equibles
AYTU $2.38 +3.48%
AYTU logo

AYTU · Aytu Biopharma, Inc

Track AYTU — free

Use AYTU with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AYTU

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.38 +0.08 (+3.48%) At close · Aug 14
Market Cap
$25.55M
Shares
10.73M
All earnings calls

Earnings call · FY2023 Q3

Aytu Biopharma, Inc Q3 FY2023 Earnings Call

Aytu Biopharma, Inc Q3 FY2023 Earnings Call

Concluded May 11, 2023
May 11, 2023 0 turns
Period
FY2023 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $22.73M -6.1% YoY
Diluted EPS -$1.93
Gross margin 56.1% +3.7 pp YoY
Net income -$7.20M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 11, 2023 10-Q report Filed May 11, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Rx Segment$13.80M
Consumer Health$8.93M -13.6% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)